Yu M W, Chen C J, Luo J C, Brandt-Rauf P W, Carney W P, Santella R M
Department of Public Health, College of Public Health, National Taiwan University, Taipei.
Cancer Res. 1994 Oct 1;54(19):5106-10.
To investigate the potential role of neu oncogene expression in hepatocarcinogenesis, a nested case-control study was conducted within a cohort of 9691 male adults in Taiwan. Blood samples of study subjects were collected during 1984-1986 and frozen at -30 degrees C until subsequent analysis. The neu oncoprotein level in the stored serum was measured by an enzyme-linked immunosorbent assay for 27 cases of newly developed hepatocellular carcinoma (HCC), 12 liver cirrhosis cases, and 40 healthy controls. The mean level of neu oncoprotein was significantly higher in HCC and liver cirrhosis cases than in controls. The risk of HCC increased significantly with increasing serum level of neu oncoprotein (trend test, P = 0.02). The proportion of subjects having an elevated serum level of neu oncoprotein, defined as a level greater than the mean level of all controls, was significantly higher among asymptomatic HBsAg carriers than noncarriers (P = 0.05), showing a multivariate-adjusted odds ratio of 4.0. Among HCC cases, a strong association was observed between cigarette smoking and elevated prediagnostic serum level of neu oncoprotein. The association remained highly significant (P = 0.017) even when adjustment was made for potential confounders. The multivariate-adjusted odds ratio of having an elevated serum level of neu oncoprotein, defined as a level greater than the mean plus 1 SD of control levels, for HCC cases who smoked more than 10 cigarettes a day was as high as 386.5 compared with the cases who smoked less than 10 cigarettes a day or nonsmoking cases. The results suggest that both HBsAg carrier status and cigarette smoking are related to the increased expression of neu oncogene, and cigarette smoking seems to play a significant role in the latter stages of hepatocarcinogenesis. There was no association between alcohol drinking and serum neu oncoprotein level.
为研究neu癌基因表达在肝癌发生中的潜在作用,在台湾9691名成年男性队列中进行了一项巢式病例对照研究。研究对象的血样于1984 - 1986年采集,并在-30℃冷冻保存直至后续分析。采用酶联免疫吸附测定法检测27例新发生的肝细胞癌(HCC)患者、12例肝硬化患者及40名健康对照者储存血清中的neu癌蛋白水平。HCC患者和肝硬化患者的neu癌蛋白平均水平显著高于对照组。随着血清neu癌蛋白水平升高,HCC发病风险显著增加(趋势检验,P = 0.02)。血清neu癌蛋白水平高于所有对照者平均水平的受试者比例,无症状HBsAg携带者显著高于非携带者(P = 0.05),多因素调整后的优势比为4.0。在HCC病例中,吸烟与诊断前血清neu癌蛋白水平升高之间存在强关联。即使对潜在混杂因素进行调整,该关联仍高度显著(P = 0.017)。与每天吸烟少于10支或不吸烟的HCC病例相比,每天吸烟超过10支的HCC病例血清neu癌蛋白水平高于对照者平均水平加1个标准差的多因素调整优势比高达386.5。结果表明,HBsAg携带者状态和吸烟均与neu癌基因表达增加有关,且吸烟似乎在肝癌发生的后期阶段起重要作用。饮酒与血清neu癌蛋白水平之间无关联。